Patel Chem Specialities Limited , a manufacturer of cellulose and starch-based pharmaceutical excipients, has reported robust financial performance for the first half of fiscal year 2026. The company's revenue and profit figures show significant growth compared to the same period in the previous year.

Financial Highlights

Patel Chem Specialities' revenue increased by 22% year-over-year, reaching ₹61.16 crore in the first half of FY2026. This growth demonstrates the company's strong market position and increasing demand for its products.

Notably, the company's Profit After Tax (PAT) also saw a significant rise, growing by 17% to reach ₹6.13 crore. This growth in both revenue and profit suggests that Patel Chem Specialities has maintained its operational efficiency while expanding its business.

Expansion and Export Performance

Patel Chem Specialities is actively expanding its production capacity to meet growing demand. Key developments include:

• The upcoming Indrad facility, which will add 6,012 MTPA to the company's production capacity.
• The Vatva expansion, which is expected to begin commercial production by December 2025.

The company continues to maintain a strong export presence, with shipments to over 15 countries. Importantly, Patel Chem Specialities reports 100% repeat orders across its major product lines, indicating high customer satisfaction and product quality.

The robust financial performance and ongoing expansion efforts of Patel Chem Specialities in the first half of FY2026 are noteworthy for investors and market watchers, particularly those focused on the pharmaceutical excipients and specialty chemicals sectors.

Patel Chem Specialities Limited , a leading chemical company, has taken a significant step towards expanding its operations by signing a major turnkey project agreement. The company has executed an Independent Turnkey Project Service Agreement with J & H Pharma Consultants for their Indrad Plant, valued at Rs 45.00 crores.

Project Details

The agreement outlines a comprehensive project scope for J & H Pharma Consultants. As per the contract, the consultant will be responsible for:

• Designing
• Engineering
• Procuring
• Constructing
• Testing

The project aims to deliver a fully operational facility to Patel Chem Specialities upon completion.

Project Location

The Indrad Plant is strategically located at:

• Survey No. 68 (old block/Survey No.44 Paikee 1 Paikee 1 adm. 15885 Sq. Meter)
• Block/Survey No. 91 (old block/Survey No.44 Paikee 1 Paikee 2 adm. 7088 Sq. Meter)
• Mouje Village, Taluka Talod

Financial Implications

The total consideration for this turnkey project is set at Rs 45.00 crores, highlighting the substantial investment Patel Chem Specialities is making in its infrastructure and capabilities.

Regulatory Compliance

In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Patel Chem Specialities has duly informed the BSE Limited about this significant development.

Independence of the Consultant

J & H Pharma Consultants is not related to the promoter or promoter group of Patel Chem Specialities. The company has explicitly stated that this transaction does not fall under related party transactions, ensuring transparency and adherence to corporate governance norms.

This strategic move by Patel Chem Specialities underscores the company's commitment to growth and operational excellence. The turnkey project is expected to enhance the company's manufacturing capabilities and potentially contribute to its long-term business objectives.